and is in Phase IIB clinical development for advanced Relapsed-Refractory Diffuse Large B Cell Lymphoma (DLBCL) and platinum resistant Ovarian Cancer. MVP-S delivers antigenic peptides from ...

B7-H3, also known as CD276, is an immunoregulatory protein that is overexpressed in tumour tissue, notably in lung, breast, ovarian, gastric, and brain cancer as well as squamous cell carcinoma of ...

non-small cell lung cancer, oesophageal, ovarian, pancreatic, and prostate). Here, the synthetic mRNA encoding tumour-associated or tumour-specific antigens can be delivered through autologous ...

Supplemental NDA accepted for review SER-155 (Seres Therapeutics) 16-strain microbiome therapeutic To reduce bloodstream infections in adults undergoing allogeneic hematopoietic stem cell transplant .

University of Virginia Cancer Center researchers have explained the failure of immune checkpoint therapy for ovarian cancer ...

Gut bacteria are to blame for the failure of immune checkpoint therapy for ovarian cancer, new research reveals.

Immunotherapy has changed the way physicians treat cancer patients. This approach to therapy targets the immune system to redirect cells toward the tumor. | Immunology ...

University of Virginia Cancer Center researchers have explained the failure of immune checkpoint therapy for ovarian cancer by discovering how gut bacteria interfere with the treatment.

A Pap smear or Pap test doesn’t help doctors detect ovarian cancer. But they use Pap smears to help them detect cervical cancer. During a Pap test, a doctor collects cells from your cervix ...

Cancer cells have special adaptation mechanisms that allow them to proliferate despite changes in their genetic makeup.